Pfizer Stock News

The Ministry of Health has notified the health unit of a shipment cancellation, which has impacted the ability of immunization clinics to access the Pfizer shot.

THE Covid-19 vaccination program has been on the right track since it began in March this year and is poised to reach its first milestone by the end of the year through different programs aimed to convince Filipinos to get vaccinated. From an initial shipment of 600,000 doses in February, the country''s stockpile grew to 160 million doses of vaccines as of December 21. So far, 101 million doses have been administered. The National Capital Region (Metro Manila) led the most number of inoculations at 19.3 million doses, followed by the Calabarzon (Cavite, Laguna, Batangas, Rizal and Quezon) Region at 14.7 million doses and Central Luzon at 11.5 million doses. Other regions are catching up, and with the government ramping up its targets, it launched the National Vaccination Day blitz program to allow more Filipinos to get vaccinated. The vaccination blitz, called "Bayanihan Bakunahan," was first held from November 29 to December 3 and set a grand 15 million target before issues regarding supply of syringes lowered its target to 9 million.

It''s based on older technology than Pfizer or Moderna

Pharmaceutical giant Pfizer is now testing a third vaccine dose in children under five, claiming two doses are not strong enough: Pfizer announced the change after preliminary analysis found the immune response to the very low-dose shots, the company is testing in the children, was not as strong as expected. The news is disappointing for

No doubt, Pfizer (PFE) is one of 2021s out-and-out success stories. The pharma giant has posted year-to-date gains of a remarkable 61%, and the company and inves

The man suffered myocarditis, a rare heart inflammation, after taking his first dose

AN official of the Department of Health (DOH) on Monday disclosed that 100 vials of Pfizer Covid-19 vaccines

New Zealands COVID-19 safety monitoring board said in a statement Monday that, based on current information available, the death of a 26-year-old man with myocarditis was likely due to the Pfizer COVID-19 vaccine, according to reports.

Pakistan has approved coronavirus booster jabs for people aged 30 and above amid fears of the new Omicron variant, it was reported on Monday. During its daily meeting on Covid-19, the National Command and Operation (NCOC) decided that eligible citizens can get their doses from January 1. They will be administered Sinopharm, Sinovac and Pfizer as booster jabs. The doses will be administered free of cost. Meanwhile, the NCOC has announced that 27% of the total population and 40% of the eligible population have been vaccinated. During the last 24 hours, 713,582 doses were administered. So far, the country has administered 141,509,339 doses of the Covid-19 vaccines. Pakistan revises travel advisory for UK The country has issued new guidelines for passengers traveling from the UK. They are now required to undergo a rapid antigen (RAT) test upon arrival, as well as the mandatory vaccination and negative PCR test pre-boarding protocols already in place. Covid-19 claims 3 more lives, infects 237 others Pakistan reports 360 new cases During the last 24 hours, the country conducted 43,242 tests out of which 360 came out positive.

From India to the world, the risk of omicrons is now increasing. This has led to fear among the people, but big news among all of them has raised the concerns of the people. In fact, according to preliminary studies conducted so far, most vaccines are not very capable of protecting against omicron infections. Preliminary research so far shows that covid-19 vaccines used in most parts of the world are not effective in preventing the rapidly spreading omicrons, although all the vaccines available in the market so far include only Pfizer and Moderna vaccines which are largely effective in preventing this infection with booster doses. However, these vaccines are still not available to most people in the world. You may all know that the risk of omicrons is increasing from India to the world at the moment, but the news in the meantime has raised the concerns of the people. According to research, other vaccines include AstraZeneca, Johnson & Johnson and vaccines manufactured in China and Russia that are not enough to prevent the spread of omicron.

Authorities in New Zealand announced on Monday that a 26-year-old man died after contracting myocarditis, a rare inflammation of the heart muscle, after receiving his first dosage of the Pfizer COVID-19 vaccine. In August, health officials revealed that a lady had died after taking her vaccine shot, making this the second death in New Zealand [] The post Pfizer COVID-19 vaccine linked to 26-year-old mans death appeared first on Revyuh .

EU members will get an additional 20 million doses of the Pfizer-BioNTech vaccine in the first three months of 2022 to fight the fast-spreading Omicron variant, the European Commission said on Sunday (19 December).

The Vancomycin Market research report provides an in-depth analysis of the current’s trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2022 and 2027